Wyeth-Ayerst Canada
|
Wyeth-Ayerst Canada Inc.
|
|
Wyeth-Ayerst Canada is owned by Wyeth, which is in turn part of American Home Products Corporation (USA) � Pharmaceutical Division. WYETH is involved in women's health, gastrointestinal diseases, infectious diseases, neuroscience, transplantation and immunology, musculoskeletal diseases, vaccines, nutritionals, hemophilia, cardiovascular diseases, oncology, and other products. Wyeth-Ayerst Laboratories concentrates its efforts on the distribution and sale of pharmaceutical and vaccine products and the distribution of Whitehall-Robins consumer products in the United States. Headquartered in St. Davids, Pennsylvania, U.S.A., the company employs approximately 15,000 people in its business operations. |
|
In Montreal, Wyeth-Ayerst produces: Wyeth-Ayerst operates the Kilo lab (synthesis of new chemical molecules used for toxicity studies and clinical research). The facility, constructed in 1998, is one of the only laboratories of its kind in Canada. The company is investing $2 million over five years to the holders of the country's first professional Clinical Research Chairs in Women's Health. One of the four Chairs, at McGill University, will conduct research into reproductive endocrinology. (Spring 2000) |
|
CEO: Aldo Baumgartner |
|
Employees: 1,100 (Ville Saint-Laurent) |
|
|
|
The mystery of premature births - includes some info on Ayerst research chairs at McGill |
If you have information that you feel should be made public regarding the activities of this corporation, send it to [email protected] Include as much factual content as possible to back up your claims. Thank you.